Item 8.01 Other Events.
On February 18, 2022, Adagio Therapeutics, Inc. (the "Company") issued a press
release entitled "Adagio Therapeutics Announces CEO Succession Plan." On
February 22, 2022, the Company issued a press release entitled "Adagio
Therapeutics Announces ADG20 Development Plans and Pipeline Updates." The press
releases are attached as Exhibit 99.1 and Exhibit 99.2 to this Current Report
on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press release, dated February 18, 2022.
99.2 Press release, dated February 22, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses